返回ChemicalBook首页>CAS数据库列表>351986-85-1

351986-85-1

中文名称 3-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
英文名称 3-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
CAS 351986-85-1
分子式 C26H24IN7O
分子量 577.42
MOL 文件 351986-85-1.mol
更新日期 2024/06/05 13:41:55
351986-85-1 结构式 351986-85-1 结构式

基本信息

中文别名
化合物VACUOLIN-1
英文别名
Vacuolin-1
Vacuolin-1 - CAS 351986-85-1 - Calbiochem
3-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
(E)-4-(2-(3-iodobenzylidene)hydrazinyl)-6-Morpholino-N,N-diphenyl-1,3,5-triazin-2-aMine
Benzaldehyde, 3-iodo-, 2-[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
4-[(2E)-2-(3-iodobenzylidene)hydrazinyl]-6-(morpholin-4-yl)-N,N-diphenyl-1,3,5-triazin-2-amine

物理化学性质

沸点719.7±70.0 °C(Predicted)
密度1.53±0.1 g/cm3(Predicted)
储存条件2-8°C
溶解度DMSO:18.33(Max Conc. mg/mL);31.74(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:7):0.12(Max Conc. mg/mL);0.21(Max Conc. mM)
DMF:3.0(Max Conc. mg/mL);5.2(Max Conc. mM)
酸度系数(pKa)10.74±0.10(Predicted)
形态白色固体

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H302-H315-H319-H335
危险品标志Xn
危险类别码22
3-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/04/30HY-1186303-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
Vacuolin-1
351986-85-15mg900元
2024/04/30S69123-Iodobenzaldehyde[4-(diphenylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
Vacuolin-1
351986-85-15mg958.24元
2024/04/30S6912Vacuolin-1351986-85-110mM (1mL in DMSO)1122.03元

常见问题列表

生物活性
Vacuolin-1 是一种有效的细胞渗透性抑制剂,可阻断 Ca(2+)-dependent exocytosis of lysosomes,并防止溶酶体内容的释放而不会影响重新封装的过程。Vacuolin-1 还是一种有效的、具有选择性的 PIKfyve 的抑制剂,通过抑制PIKfyve的溶酶体成熟来抑制自噬。
靶点
TargetValue
PIKfyve
()
体外研究

Vacuolin-1 (1 μM; Pretreatment 1 hour) blocks ionomycin-induced exocytosis of lysosomes but not of enlargeosomes. It results in vacuolation of lysosomes (A) and complete inhibition of the surface expression of Lamp-1. Vacuolin-1 (1 μM; 20-180 min) disrupts the segregation of inner and limiting membranes characteristic of endosomes and lysosomes. Ultrastructural analysis also shows that vacuolin-1 favours fusion of inner and limiting membranes. Vacuolin-1 (5 or 10 μM; 2 hours) blocks the Ca 2+ -dependent release of β-hexosaminidase from lysosomes. In HeLa cells, ionomycin results in the expected release of 18-20% of lysosomal β-hexosaminidase. But when cells pretreated with vacuolin-1, releases no more β-hexosaminidase compared with cells that are not exposed to ionomycin (4%).

"351986-85-1" 相关产品信息
148893-10-1